Interestingly, almost half of patients with TACI defects in our cohort exhibited recurrent attacks of autoimmune hematologic complications (autoimmune hemolytic anemia, autoimmune thrombocytopenia or Evans syndrome), and the difference compared to patients with no mutations was also statistically significant (Table 3). Here, TNFRSF13B is linked to autoimmune thrombocytopenia.